T21	Symptom 1223 1229	VD (HR
T20	Characteristic 1113 1147	Larger FAZ area (hazard ratio [HR]
T23	Anatomy 1342 1345	DCP
T22	Characteristic 1280 1292	lower FD (HR
T25	Disease 1442 1444	DR
T24	Disease 1381 1383	DR
T27	Characteristic 1550 1569	Lower VD of SCP (HR
T26	Characteristic 1476 1535	duration of diabetes, age, and mean arterial blood pressure
T29	Diagnostic_tool 1729 1733	OCTA
T28	Disease 1635 1638	DME
T1	Diagnostic_tool 0 23	OCT Angiography Metrics
T2	Disease 47 67	Diabetic Retinopathy
T3	Disease 87 109	Diabetic Macular Edema
T4	Diagnostic_tool 180 238	OCT angiography (OCTA) metrics to diabetic retinopathy (DR
T5	Disease 271 293	diabetic macular edema
T6	Disease 295 298	DME
T7	Anatomy 350 354	eyes
T8	Disease 378 395	diabetes mellitus
T9	Diagnostic_tool 457 536	OCTA with a swept-source OCT device (DRI-OCT Triton, Topcon, Inc, Tokyo, Japan)
T30	Disease 1784 1786	DR
T10	Diagnostic_tool 549 629	OCTA images of superficial capillary plexus (SCP) and deep capillary plexus (DCP
T32	Characteristic 2044 2138	FAZ area, VD, and FD of DCP predict DR progression, whereas VD of SCP predicts DME development
T31	Characteristic 1800 1996	FAZ area of DCP, C-statistics 0.723 vs. 0.677, P  <  0.001; VD of DCP, C-statistics 0.727 vs. 0.677, P = 0.001; FD of DCP, C-statistics 0.738 vs. 0.677, P  <  0.001) and DME development (VD of SCP
T12	Characteristic 702 846	automated measurements of foveal avascular zone (FAZ) area, FAZ circularity, vessel density (VD), and fractal dimension (FD) of both SCP and DCP
T34	Disease 2252 2255	DME
T11	Diagnostic_tool 649 677	IMAGEnet6 (Basic License 10)
T33	Disease 2233 2235	DR
T14	Disease 904 907	DME
T13	Disease 882 884	DR
T16	Disease 1030 1032	DR
T15	Anatomy 1006 1010	eyes
T18	Disease 1070 1073	DME
T17	Anatomy 1057 1061	eyes
T19	Disease 1108 1111	DME
